Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Aug 30, 2024

SELL
$2.21 - $3.22 $14,365 - $20,930
-6,500 Closed
0 $0
Q2 2021

Aug 30, 2024

BUY
$2.61 - $4.17 $16,965 - $27,105
6,500 New
6,500 $21.8 Million
Q3 2020

Aug 30, 2024

SELL
$2.77 - $6.17 $1,385 - $3,085
-500 Reduced 7.14%
6,500 $18.6 Million
Q2 2020

Aug 30, 2024

BUY
$0.87 - $3.13 $5,655 - $20,345
6,500 Added 1300.0%
7,000 $21.7 Million
Q1 2019

Aug 30, 2024

SELL
$1.54 - $2.01 $8,400 - $10,964
-5,455 Reduced 91.6%
500 $935,000
Q4 2018

Aug 30, 2024

BUY
$1.22 - $2.41 $7,265 - $14,351
5,955 New
5,955 $9.53 Million
Q3 2018

Aug 30, 2024

BUY
$1.75 - $2.93 $3,150 - $5,274
1,800 Added 43.32%
5,955 $14.4 Million
Q4 2017

Aug 30, 2024

BUY
$3.29 - $5.03 $12,173 - $18,611
3,700 Added 813.19%
4,155 $17.3 Million
Q2 2017

Aug 30, 2024

BUY
N/A
455
455 $1.96 Million

Others Institutions Holding VBIV

About VBI Vaccines Inc


  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $5.17M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.